Targeting NLRP3 inflammasome activation in styrene-induced ototoxicity: comparative efficacy of rosmarinic acid and anakinra in mitigating oxidative and inflammatory damage
Authors:
- 6 October 2025
- journal article
- Published by Taylor & Francis in International Journal of Audiology
- Vol. 65 (5) , 525-538
Abstract
Styrene is a known ototoxic drug, causing increased oxidative stress and inflammation in cochlear structures. The aim of this study is exploring the possible involvement of NRLP3 inflammasome in mediating the interplay between oxidative stress and inflammation in a model of styrene ototoxicity and to compare the effectiveness of two therapeutic strategies. Styrene was administered 400 mg/kg, 5 days a week for 3 consecutive weeks in Wistar rats. An antioxidant (rosmarinic acid, 10 mg/kg), and an anti-inflammatory (anakinra, 30 mg/kg) drugs were used to evaluate the protective effects on auditory function. At the end of treatments functional, morphological and molecular analyses were used to study the mechanisms underlying ototoxicity and otoprotection. Study sample: 66 male adult Wistar rats. Results: Both antioxidant and anti-inflammatory treatments significantly reduced oxidative stress, NLRP3 inflammasome activation, and inflammatory markers. However, anakinra provided the best protective effect, with earlier hearing recovery and greater suppression of inflammation. 66 male adult Wistar rats of 2 months of age. Functional and molecular analyses revealed that both treatments significantly reduced oxidative stress, NLRP3 inflammasome activation, and inflammatory markers. However, anakinra provided the best protective effect, as evidenced by earlier auditory threshold recovery and greater suppression of inflammation. These findings underscore the pivotal role of inflammation in styrene-induced ototoxicity, highlighting NLRP3 inflammasome activation as a central mediator linking oxidative and inflammatory damage. Our results suggest that targeting inflammation provides a more comprehensive and timely intervention for styrene ototoxicity. The dual mechanism of action of anakinra (reducing NLRP3 levels and directly modulating IL-1β) makes it a promising candidate for mitigating cochlear damage caused by environmental and toxic insults.Keywords
Funding Information
- Istituto Nazionale per l'Assicurazione Contro Gli Infortuni sul Lavoro (BRIC id08 PAR 2022-2024)
This publication has 59 references indexed in Scilit:
- Regulation of NLRPs by reactive oxygen species: A story of crosstalkBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2024
- NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigmaJournal of Leukocyte Biology, 2020
- Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer diseaseJournal of Neuroscience Research, 2016
- Characterisation of cochlear inflammation in mice following acute and chronic noise exposureHistochemistry and Cell Biology, 2016
- Molecular Mechanism of NLRP3 Inflammasome ActivationJournal of Clinical Immunology, 2010
- Age-related hearing loss or presbycusisEuropean Archives of Oto-Rhino-Laryngology, 2010
- The influence of NF‐κB signal‐transduction pathways on the murine inner ear by acoustic overstimulationJournal of Neuroscience Research, 2009
- Proinflammatory cytokines expression in noise-induced damaged cochleaJournal of Neuroscience Research, 2006
- Relative ototoxicity of 21 aromatic solventsArchives of Toxicology, 2005
- Anti‐inflammatory and anti‐allergic effect of rosmarinic acid (RA); inhibition of seasonal allergic rhinoconjunctivitis (SAR) and its mechanismBioFactors, 2004